Table 4 Time to brain progression (TTBP) and overall survival (OS) according to the type of treatment for brain metastases

BPF^a survival at 1 year

80 %

76 %

62 %

BPF survival at 2 years

71 %

53.5 %

34 %

median TTBP

27 months

25 months

14 months

(C.I. 95%:16-21)

(C.I. 95%:20-30)

(C.I. 95%:11-17)

1 year OS

74.9 %

47.3 %

33.6 %

2 years OS

42.1 %

23 %

11.5 %

median OS

18 months

10 months

8 months

(C.I. 95%:26-28)

(C.I. 95%:7-14)

(C.I. 95%:7-10)